- Company
Austria
Germany
- Aixtron SE
- Brain Biotech AG
- Carl Zeiss Meditec AG
- Deutz AG
- Edag Engineering Group AG
- ElringKlinger AG
- Encavis AG
- Energiekontor AG
- Hypoport SE
- Jost Werke SE
- Knaus Tabbert AG
- LEG Immobilien SE
- Media and Games Invest SE
- Mister Spex SE
- Mountain Alliance AG
- Mutares SE
- Nemetschek SE
- Rational AG
- Schaltbau Holding AG
- SFC Energy AG
- Sixt SE
- Talanx AG
- Varta AG
- voxeljet AG
- Wacker Chemie AG
- Zeal Network SE
Poland
Estonia
Italy
Finland
- Sector
- Index
- Verticals
- Speaker
- About
- Blog
Carl Zeiss Meditec AG Elevator Pitch 2023 | Embracing the Future of MedTech with IR
June 27, 2023-
06:20
- Investor Relations
June 27, 2023
06:20 
Excerpt
In this captivating presentation by Carl Zeiss Meditec, Sebastian Frericks, the Head of Group Finance and Investor Relations, provides an insightful overview of their operations and strategic advantages. The video focuses on the company’s commitment to improving the quality of patient lives through technology and innovation, exemplified by their ground-breaking medical innovations such as Smile Technology for minimally invasive laser surgery and 4K video technology for eye surgeries.
Sebastian highlights the company’s impressive financial track record, featuring a robust 10% CAGR and EBIT margin exceeding 20%. This success, he reveals, is driven by four key factors:
- Relentless innovation
- A growing base of recurring revenue
- Strategic focus on the high-growth Asia-Pacific region
- A forward-thinking approach to the digitalization of their product portfolio
Zeiss Meditec’s strong commitment to R&D has fostered pioneering innovations in neurosurgery and ophthalmology, positioning them at the cutting edge of medical technology. Moreover, their recurring business model, comprising 46% of their revenue, ensures a robust financial base underpinned by surgical consumables, implants, and service fees.
The company’s keen focus on the Asia-Pacific region reflects an astute recognition of the high-growth potential in markets such as China. Lastly, Zeiss Meditec is harnessing the power of digitalization, connecting devices for seamless workflows, employing data management tools, and utilizing artificial intelligence for improved treatment outcomes.
In conclusion, Zeiss Meditec presents a compelling case for investors, with a track record of innovation, a steady stream of recurring revenue, a strong foothold in high-growth markets, and a future-oriented approach to digitalization.
Chapters
Resources
Host
Share
T&C:
This publication is for informational purposes only and should not be considered investment advice. By using this website, you agree to the terms and conditions outlined in the legal pages at www.seat11a.com/legal/
Discover Additional Elevator Pitches
COMPANIES:
Aixtron SE
Brain Biotech AG
Carl Zeiss Meditec AG
Deutz AG
Edag Engineering Group AG
ElringKlinger AG
Encavis AG
Energiekontor AG
Hypoport SE
Jost Werke AG
Knaus Tabbert AG
LEG Immobilien SE
Media and Games Invest SE
Mister Spex SE
Mountain Alliance AG
Multitude SE
Mutares SE & Co. KGaA
Nemetschek SE
Rational AG
Schaltbau Holding AG
SFC Energy AG
Sixt SE
Talanx AG
Varta AG
voxeljet AG
Wacker Chemie AG
Zeal Network SE
seat11a – Publicly Listed Companies: Elevator Pitch, Deep-Dive, Financial Results, and ESG
Unlock the insights of top publicly listed companies with seat11a.com
Elevate your understanding with powerful Elevator Pitches, Deep-Dive Presentations, and in-depth Financial Analysis
Reviews for Carl Zeiss Meditec AG Elevator Pitch 2023 | Embracing the Future of MedTech with IR